Inpatient Closed-loop Glucose Control

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

December 31, 2014

Conditions
Diabetes MellitusHyperglycemia
Interventions
DEVICE

Closed-loop blood glucose control

The InPatient Closed Loop Device is made up of the three components; the Abbott FreeStyle Navigator subcutaneous continuous glucose monitor, the Symbiq insulin-dextrose infusion system, and the control algorithm. In this feasibility trial we will study 6 insulin-sensitive subjects with type 1 diabetes and 6 subjects with type 2 diabetes and a high insulin requirement (3 with total daily dose from 1-1.9 u/kg and 3 with total daily dose \> 2 u/kg).

Trial Locations (1)

02114

MGH Diabetes Research Center, Boston

All Listed Sponsors
collaborator

Boston University

OTHER

lead

Massachusetts General Hospital

OTHER

NCT01819844 - Inpatient Closed-loop Glucose Control | Biotech Hunter | Biotech Hunter